U.S. Monoclonal Antibodies In Veterinary Health Market Size & Outlook
Related Markets
U.S. monoclonal antibodies in veterinary health market highlights
- The U.S. monoclonal antibodies in veterinary health market generated a revenue of USD 390.4 million in 2024 and is expected to reach USD 1,050.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 17.7% from 2025 to 2030.
- In terms of segment, dogs was the largest revenue generating animal type in 2024.
- Dogs is the most lucrative animal type segment registering the fastest growth during the forecast period.
Monoclonal antibodies in veterinary health market data book summary
| Market revenue in 2024 | USD 390.4 million |
| Market revenue in 2030 | USD 1,050.1 million |
| Growth rate | 17.7% (CAGR from 2025 to 2030) |
| Largest segment | Dogs |
| Fastest growing segment | Dogs |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dogs |
| Key market players worldwide | Zoetis Inc Class A, Merck & Co Inc, Elanco Animal Health Inc, Virbac SA, Boehringer Ingelheim, Indian Immunologicals |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.1% of the global monoclonal antibodies in veterinary health market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. monoclonal antibodies in veterinary health market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 147.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Monoclonal Antibodies In Veterinary Health Market Scope
Monoclonal Antibodies In Veterinary Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Indian Immunologicals | View profile | 1001-5000 | Hyderabad, Andhra Pradesh, India, Asia | https://indimmune.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Elanco Animal Health Inc | View profile | 9800 | 2500 Innovation Way, Greenfield, IN, United States, 46140 | https://www.elanco.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Virbac SA | View profile | 5400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | https://www.virbac.com |
| Zoetis Inc Class A | View profile | 14100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | https://www.zoetis.com |
U.S. monoclonal antibodies in veterinary health market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to monoclonal antibodies in veterinary health market will help companies and investors design strategic landscapes.
Dogs was the largest segment with a revenue share of 113.4% in 2024. Horizon Databook has segmented the U.S. monoclonal antibodies in veterinary health market based on dogs covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. monoclonal antibodies in veterinary health market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. monoclonal antibodies in veterinary health market databook
-
Our clientele includes a mix of monoclonal antibodies in veterinary health market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. monoclonal antibodies in veterinary health market , including forecasts for subscribers. This country databook contains high-level insights into U.S. monoclonal antibodies in veterinary health market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
US Animal Type - Monoclonal Antibodies In Veterinary Health Market size, 2024 - 2030 (US$M)
U.S. Monoclonal Antibodies In Veterinary Health Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
